Joslin International Symposium 2025 Resource Hub –
Welcome to our resource hub for Joslin Diabetes International Symposium 2025! This is a one-stop-shop for all your Joslin Diabetes International Symposium 2025 needs. We will be updating the resource hub daily, so check back in for the latest on this fantastic meeting.
Table of Contents []
Day-of Conference Reports
Top Highlights
- Dr. Lotte Bjerre Knudsen on the past, present, and future of GLP-1 RAs
- Beyond the endocrine system: Understanding miRNAs and plasma metabolites as regulators of metabolic disease
- Homeostasis of weight, and what it means for weight cycling and natural set points
- Packed two‑level hall showcases poster presentations on epigenetics, brown fat signaling, and translational therapeutics
- Substrate overload: A nontraditional, predictive model to map disease and therapy
- Dr. Barbara Kahn highlights novel regulators of signaling lipids with applications for diabetes management in a multi-omics approach
- Role of fibroblast growth factor 21 (FGF21) in liver-directed pharmacology
- Cortisol-lowering therapy for T2D: Dr. Jason Bini reviews therapeutic potential in cardiometabolic disease
- Metabolism in gut microbiota: Gut synthesizes insulin through orally bioavailable FOXO1 inhibitors in T1D
- Leptin resistance in obesity: A potential therapeutic target
- Modern understanding of microbiome as potential source of metabolic resilience
- Physiological responses to bariatric surgery: Why we should continue studying it in an era of GLP-1 RAs
- Dr. Philipp Scherer’s closing keynote: “How losing weight makes fat cells talk smarter”
- A potential new strategy for T2D prevention: Treating paternal metabolic disease before conception
- Epigenetic memory in adipose tissue may serve as a barrier to sustained weight loss
- Using genomic analysis to identify cluster associations with outcomes in obesity